A detailed history of Mwa Asset Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Mwa Asset Management holds 265 shares of LLY stock, worth $215,129. This represents 0.16% of its overall portfolio holdings.

Number of Shares
265
Previous 266 0.38%
Holding current value
$215,129
Previous $241 Million 2.52%
% of portfolio
0.16%
Previous 0.17%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$772.14 - $960.02 $772 - $960
-1 Reduced 0.38%
265 $235 Million
Q2 2024

Jul 26, 2024

SELL
$724.87 - $909.04 $724 - $909
-1 Reduced 0.37%
266 $241 Million
Q1 2024

May 08, 2024

BUY
$592.2 - $792.28 $158,117 - $211,538
267 New
267 $208 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $771B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mwa Asset Management Portfolio

Follow Mwa Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mwa Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Mwa Asset Management with notifications on news.